IL6 and rheumatic disorder: The effectiveness of IL-6 targeting in combination with corticosteroids was already shown for severe cases of acute COVID-19,78,79 and TNF blockade might be beneficial in acute COVID-19 as suggested by small observational case studies,87 in addition to its long history as therapeutic for a variety of rheumatic diseases characterized by chronic TNF elevations.